Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13078)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2019 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Suzuki S, Esaki M, Kusano C, Ikehara H, Gotoda T. Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance? World J Gastroenterol 2019; 25(16): 1907-1912 [PMID: 31086459 DOI: 10.3748/wjg.v25.i16.1907] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i16/1907.htm |
| Number | Citing Articles |
| 1 |
Yongfu Shao, Yifan Lin, Ziyi Fang, Jianing Yan, Tuo Zheng, Guoliang Ye. Analysis of Helicobacter pylori resistance in patients with different gastric diseases. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55589-2
|
| 2 |
Najmeh Salehi, Bahareh Attaran, Fatemeh Zare‐Mirakabad, Bahareh Ghadiri, Maryam Esmaeili, Mohadeseh Shakaram, Mohammad Tashakoripour, Mahmoud Eshagh Hosseini, Marjan Mohammadi. The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains. Helicobacter 2020; 25(6) doi: 10.1111/hel.12731
|
| 3 |
Jessica Rodrigues Pereira de Oliveira Borlot, Luna Schlittler dos Santos, Guilherme José Schwarzt Sampaio, Augusto Santos Borges, Ricardo Pereira Rodrigues, Rita de Cássia Ribeiro Gonçalves, Reginaldo Bezerra dos Santos, Rodrigo Rezende Kitagawa. Synthesis, Docking Studies and Evaluation of Chalcones as Anti‐Helicobacter pylori and antitumoral Agents. Chemistry & Biodiversity 2023; 20(10) doi: 10.1002/cbdv.202301066
|
| 4 |
Lyudmila Boyanova, Rumyana Markovska, Petyo Hadzhiyski, Nayden Kandilarov, Ivan Mitov. Rifamycin use for treatment of Helicobacter pylori infection: a review of recent data. Future Microbiology 2020; 15(12): 1185 doi: 10.2217/fmb-2020-0084
|
| 5 |
Wen-Ting Zhou, Yuan-Yuan Dai, Li-Juan Liao, Shi-Xian Yang, Hao Chen, Liang Huang, Juan-Li Zhao, Yan-Qiang Huang. Linolenic acid-metronidazole inhibits the growth of <i>Helicobacter pylori</i> through oxidation. World Journal of Gastroenterology 2023; 29(32): 4860-4872 doi: 10.3748/wjg.v29.i32.4860
Abstract(298) |
Core Tip(332) |
Full Article(HTML)(1183)
|
Full Article with Cover (PDF)-11402K(56)
|
Full Article (Word)-3725K(31)
|
Audio-1140K(2)
|
Peer-Review Report-205K(19)
|
Answering Reviewers-111K(25)
|
Full Article (PDF)-11156K(95)
|
Full Article (XML)-84K(24)
|
Times Cited (1)
|
Total Visits (3906)
|
Open
|
| 6 |
Rocío Bonoso Criado, Laura Pérez Citores, Antonio Germán Pérez-Millán, Ángela Martina Montero Moretón, Elena González De Castro, Luis Cabezudo Molleda, María Antonia García Castro, Bruno Antonio Moreira Da Silva, Sergio Maestro Antolín, Fernando Santos Santamarta, Javier Barcenilla Laguna. PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA�. Revista Española de Enfermedades Digestivas 2020; doi: 10.17235/reed.2020.7395/2020
|
| 7 |
Sepehr Asadi, Ebrahim Rahimi, Amir Shakerian. Helicobacter pylori Strains Isolated from Raw Poultry Meat in the Shahrekord Region, Iran: Frequency and Molecular Characteristics. Genes 2023; 14(5): 1006 doi: 10.3390/genes14051006
|
| 8 |
Margarita Camorlinga-Ponce, Alejandro Gómez-Delgado, Emmanuel Aguilar-Zamora, Roberto C. Torres, Silvia Giono-Cerezo, Antonio Escobar-Ogaz, Javier Torres. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México. Frontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.539115
|
| 9 |
Meenakshi Kandpal, Budhadev Baral, Nidhi Varshney, Ajay Kumar Jain, Debi Chatterji, Ajay Kumar Meena, Rajan Kumar Pandey, Hem Chandra Jha.
Gut-brain axis interplay via STAT3 pathway: Implications of
Helicobacter pylori
derived secretome on inflammation and Alzheimer’s disease
. Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2303853
|
| 10 |
Lyudmila Boyanova, Petyo Hadzhiyski, Raina Gergova, Rumyana Markovska. Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern. Antibiotics 2023; 12(2): 332 doi: 10.3390/antibiotics12020332
|
| 11 |
Ligang Liu, Fang Li, Hekai Shi, Milap C. Nahata. The Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Infection: A Systematic Review and Network Meta-Analysis. Antibiotics 2023; 12(2): 346 doi: 10.3390/antibiotics12020346
|
| 12 |
Mahdieh Yarmohammadi, Abbas Yadegar, Maryam Tajabadi Ebrahimi, Mohammad Reza Zali. Effects of a Potential Probiotic Strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-Induced Inflammatory Response and Gene Expression in Coinfected Gastric Epithelial Cells. Probiotics and Antimicrobial Proteins 2021; 13(3): 751 doi: 10.1007/s12602-020-09721-z
|
| 13 |
Fumiaki Ishibashi, Sho Suzuki, Mizuki Nagai, Kentaro Mochida, Tetsuo Morishita. Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments. Gut and Liver 2023; 17(5): 684 doi: 10.5009/gnl220429
|
| 14 |
Saray Mormeneo Bayo, Alba Bellés Bellés, Diego Vázquez Gómez, Montserrat Planella de Rubinat, Diana Carolina Bayas Pastor, Arturo Morales Portillo, Alfredo Jover Sáenz, Éric López González, Núria Prim, Mercè García-González. Antibiotic Susceptibility and Clarithromycin Resistance Determinants in Helicobacter pylori in the Northeast of Spain: A One-Year Prospective Study. Antibiotics 2023; 12(2): 356 doi: 10.3390/antibiotics12020356
|
| 15 |
Esayas Kebede Gudina, Hiwot Amare, Solomon Ali, Melkamu Berhane Arefayine, Dagmawi Tewolde, Million Tesfaye Eshete, Mulusew Gerbaba Jebena, Andreas Wieser, Guenter Froeschl, Markos Tesfaye, Hailemichael Desalegn, Mulatu Gashaw, Alessandro Granito. Diagnostic Challenges of Helicobacter pylori Infection in Ethiopia: A Community-Based Cross-Sectional Study. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/4013020
|
| 16 |
梓铭 孙. Advances in the Study of Vonoprazan in the Treatment of Helicobacter pylori Infection. Advances in Clinical Medicine 2024; 14(03): 1145 doi: 10.12677/ACM.2024.143822
|
| 17 |
Yongfu Shao, Yifan Lin, Bojun Wang, Min Miao, Guoliang Ye. Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021. Helicobacter 2022; 27(5) doi: 10.1111/hel.12920
|
| 18 |
James Guoxian Huang, Si Ying Sheryl Lim, Marion Margaret Aw, Seng‐Hock Quak. Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high‐migrant Singaporean cohort. Helicobacter 2022; 27(1) doi: 10.1111/hel.12868
|
| 19 |
Shubha Bhat, David Nunes. Pharmacist-Managed Helicobacter pylori Treatment Service Within a Gastroenterology Clinic: Workflow and Real-World Experiences. Annals of Pharmacotherapy 2022; 56(2): 162 doi: 10.1177/10600280211021501
|
| 20 |
Xiao-Hua Li, Yong-Yi Huang, Lin-Ming Lu, Li-Juan Zhao, Xian-Ke Luo, Ru-Jia Li, Yuan-Yuan Dai, Chun Qin, Yan-Qiang Huang, Hao Chen. Early genetic diagnosis of clarithromycin resistance in <i>Helicobacter pylori</i>. World Journal of Gastroenterology 2021; 27(24): 3595-3608 doi: 10.3748/wjg.v27.i24.3595
|
| 21 |
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?. Revista de Gastroenterología de México (English Edition) 2022; 87(3): 330 doi: 10.1016/j.rgmxen.2022.06.003
|
| 22 |
Xiaopeng Zou, Jing Hu, Ming Zhao, Chunjun Qin, Yuntao Zhu, Guangzong Tian, Juntao Cai, Peter H. Seeberger, Jian Yin. Chemical Synthesis of the Highly Sterically Hindered Core Undecasaccharide of Helicobacter pylori Lipopolysaccharide for Antigenicity Evaluation with Human Serum. Journal of the American Chemical Society 2022; 144(32): 14535 doi: 10.1021/jacs.2c03068
|
| 23 |
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategies. Critical Reviews in Microbiology 2022; 48(3): 376 doi: 10.1080/1040841X.2021.1975643
|
| 24 |
Amina Mohamed Elrais, Walid S. Arab, Khalid Ibrahim Sallam, Walaa Abd Elmegid, Fatma Elgendy, Walid Elmonir, Kálmán Imre, Adriana Morar, Viorel Herman, Haitham Elaadli. Prevalence, Virulence Genes, Phylogenetic Analysis, and Antimicrobial Resistance Profile of Helicobacter Species in Chicken Meat and Their Associated Environment at Retail Shops in Egypt. Foods 2022; 11(13): 1890 doi: 10.3390/foods11131890
|
| 25 |
Jing Yu, Peng Yang, Xiangrong Qin, Chunjian Li, Yiming Lv, Xiaoyong Wang. Impact of smoking on the eradication of Helicobacter pylori. Helicobacter 2022; 27(1) doi: 10.1111/hel.12860
|
| 26 |
Yuichiro Noiri, Ryoko Nagata. Current status of gastric and oral infection/diseases caused by Helicobacter pylori. Oral Science International 2023; 20(3): 182 doi: 10.1002/osi2.1172
|
| 27 |
Omnia Momtaz Al-Fakhrany, Engy Elekhnawy. Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents. Archives of Microbiology 2023; 205(9) doi: 10.1007/s00203-023-03639-0
|
| 28 |
Ligang Liu, Milap C. Nahata. Vonoprazan With Amoxicillin or Amoxicillin and Clarithromycin for the Treatment of Helicobacter pylori Infection. Annals of Pharmacotherapy 2023; 57(10): 1185 doi: 10.1177/10600280221149708
|
| 29 |
Marta Ilona Wojtyś, Radosław Jaźwiec, Saša Kazazić, Ivana Leščić Ašler, Petar Knežević, Verica Aleksić Sabo, Marija Luić, Elżbieta Katarzyna Jagusztyn-Krynicka, Agnieszka Bzowska. A comprehensive method for determining cellular uptake of purine nucleoside phosphorylase and adenylosuccinate synthetase inhibitors by H. pylori. Applied Microbiology and Biotechnology 2021; 105(20): 7949 doi: 10.1007/s00253-021-11510-9
|
| 30 |
Xin-Yi Feng, Yun Zhang, Bin Deng. Progress in research of high-dose dual therapy as an eradication protocol for Helicobacter pylori infection. World Chinese Journal of Digestology 2020; 28(17): 847 doi: 10.11569/wcjd.v28.i17.847
|
| 31 |
Vladimir Milivojevic, Tomica Milosavljevic. Burden of Gastroduodenal Diseases from the Global Perspective. Current Treatment Options in Gastroenterology 2020; 18(1): 148 doi: 10.1007/s11938-020-00277-z
|
| 32 |
Pei‐Ying Zou, Jie Hu, Jing‐Tao Zhao, Zhe Zhao, Hao Mei, Jing Yang, Yang‐Jie Zhu, Yi Zhang, Chun‐Hui Lan. 10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis. Helicobacter 2021; 26(5) doi: 10.1111/hel.12833
|
| 33 |
Danmei Tian, Xiaoshuang Gou, Jia Jia, Jihua Wei, Mingxin Zheng, Wenjuan Ding, Hongkai Bi, Bin Wu, Jinshan Tang. New diketopiperazine alkaloid and polyketides from marine-derived fungus Penicillium sp. TW58-16 with antibacterial activity against Helicobacter pylori. Fitoterapia 2022; 156: 105095 doi: 10.1016/j.fitote.2021.105095
|
| 34 |
A. A. Sheptulin, Yu. S. Rabotyagova. Нow to increase the effectiveness of eradication therapy of <i>Helicobacter pylori</i> infection?. Clinical Medicine (Russian Journal) 2022; 100(1): 47 doi: 10.30629/0023-2149-2022-100-1-47-50
|
| 35 |
Irena Mladenova. Clinical Relevance of Helicobacter pylori Infection. Journal of Clinical Medicine 2021; 10(16): 3473 doi: 10.3390/jcm10163473
|
| 36 |
Yousaf Khan, Wajid Rehman, Rafaqat Hussain, Shoaib Khan, Aneela Maalik. Benzothiazole-based 1,3,4-thiadiazole hybrids derivatives as effective inhibitors of urease and thymidine phosphorylase: Synthesis, in vitro and in silico approaches. Journal of Molecular Structure 2023; 1291: 135945 doi: 10.1016/j.molstruc.2023.135945
|
| 37 |
Sevgi Kalkanli Tas, Duygu Kirkik, Derya Altunkanat, Aylin Seher Uzunoglu, Merve Saide Uzunoglu, Bengu Akcam Celik, Elifnaz Ilgar. Immune Response and Therapeutic Vaccination against Helicobacter pylori. Brazilian Archives of Biology and Technology 2023; 66 doi: 10.1590/1678-4324-2023230123
|
| 38 |
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H.pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?. Revista de Gastroenterología de México 2022; 87(3): 330 doi: 10.1016/j.rgmx.2022.01.007
|
| 39 |
Milica Ristić, Bojan Korica, Vladimir Milivojević. Frequency of Helicobacter pylori infection and antibiotic resistance in patients with acute liver decompensation. Medicinski podmladak 2023; 74(5): 62 doi: 10.5937/mp74-39601
|
| 40 |
Natália Aniceto, Vasco D. B. Bonifácio, Rita C. Guedes, Nuno Martinho. Exploring the Chemical Space of Urease Inhibitors to Extract Meaningful Trends and Drivers of Activity. Journal of Chemical Information and Modeling 2022; 62(15): 3535 doi: 10.1021/acs.jcim.2c00150
|
| 41 |
Saghi Sepehri, Mina Khedmati. An overview of the privileged synthetic heterocycles as urease enzyme inhibitors: Structure–activity relationship. Archiv der Pharmazie 2023; doi: 10.1002/ardp.202300252
|
| 42 |
Xin Jiang, Bin Deng, Xuefeng Gao, Yun Zhang, Guangyao Li, Guiqing Li, Qiang She, Yanbing Ding. Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0722
|
| 43 |
Paula Roszczenko-Jasińska, Marta Ilona Wojtyś, Elżbieta K. Jagusztyn-Krynicka. Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets. Applied Microbiology and Biotechnology 2020; 104(23): 9891 doi: 10.1007/s00253-020-10945-w
|
| 44 |
Hussamaldeen Jaradat, Ammar Al-Hamry, Mohammed Ibbini, Najla Fourati, Olfa Kanoun. Novel Sensitive Electrochemical Immunosensor Development for the Selective Detection of HopQ H. pylori Bacteria Biomarker. Biosensors 2023; 13(5): 527 doi: 10.3390/bios13050527
|
| 45 |
Ali Bin-Hameed Eidha, Mohammed Barajash Huda. Screening for the prevalence of Helicobacter pylori infection among dyspeptic patients using simple fecal antigen and serum antibody diagnostic methods at Mukalla city Hospitals, Hadhramout, Yemen. African Journal of Microbiology Research 2021; 15(6): 325 doi: 10.5897/AJMR2020.9413
|
| 46 |
Qin Tang, Zhengcai Ma, Xiang Tang, Yan Liu, Huimin Wu, Yu Peng, Baihua Jiao, Rui Wang, Xiaoli Ye, Hang Ma, Xuegang Li. Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo. Journal of Ethnopharmacology 2023; 314: 116618 doi: 10.1016/j.jep.2023.116618
|
| 47 |
Xiaohua Hou, Fandong Meng, Jiangbin Wang, Weihong Sha, Cheng‐Tang Chiu, Woo Chul Chung, Liqun Gu, Kentarou Kudou, Chui Fung Chong, Shutian Zhang. Vonoprazan non‐inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients. Journal of Gastroenterology and Hepatology 2022; 37(7): 1275 doi: 10.1111/jgh.15837
|
| 48 |
Wen Gao, Guigen Teng, Chi Wang, Ying Xu, Yixuan Li, Hong Cheng. Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real‐world, retrospective clinical study in China. Helicobacter 2022; 27(5) doi: 10.1111/hel.12918
|
| 49 |
Samina Khan Bashir, Muhammad Bashir Khan, Jian Wu. Overview of Helicobacter pylori Infection, Prevalence, Risk Factors, and Its Prevention. Advanced Gut & Microbiome Research 2023; 2023: 1 doi: 10.1155/2023/9747027
|
| 50 |
Junyi Zhou, Minna Zhang, HongGang Wang, Xiaomin Zhong, XiaoZhong Yang. Role of Helicobacter pylori virulence factors and alteration of the Tumor Immune Microenvironment: challenges and opportunities for Cancer Immunotherapy. Archives of Microbiology 2024; 206(4) doi: 10.1007/s00203-024-03908-6
|
| 51 |
Meng-Yan Cui, Meng-Jie Zhang, Qiao-Li Jiang, Zhong-Mei Pei, Zhen-Yu Cui, Mei Kang, Lun-Gen Lu, Ying-Ying Lu. Can vitamin B6 alleviate the adverse reactions of quadruple anti-Helicobacter pylori regimen? : randomized controlled trial. BMC Infectious Diseases 2023; 23(1) doi: 10.1186/s12879-023-08571-8
|
| 52 |
Qianyu Ji, Junfei Ma, Shuying Wang, Qing Liu. Embedding of exogenous B cell epitopes on the surface of UreB structure generates a broadly reactive antibody response against Helicobacter pylori. Immunology 2024; 171(2): 212 doi: 10.1111/imm.13703
|
| 53 |
Yu Sasaki, Yasuhiko Abe, Masakuni Shoji, Naoko Mizumoto, Hiroaki Takeda, Harufumi Oizumi, Takao Yaoita, Norie Sawada, Kazumasa Yamagishi, Eiko Saito, Masafumi Watanabe, Kenichi Ishizawa, Tsuneo Konta, Takamasa Kayama, Shoichiro Tsugane, Yoshiyuki Ueno, Manami Inoue. Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95124-1
|
| 54 |
Suthathip Kittisenachai, Panadda Rojpibulstit, Ratha-Korn Vilaichone, Pornpen Gamnarai, Narumon Phaonakrop, Nuchanart Suealek, Denise Monack. FBPAII and rpoBC, the Two Novel Secreted Proteins Identified by the Proteomic Approach from a Comparative Study between Antibiotic-Sensitive and Antibiotic-Resistant Helicobacter pylori-Associated Gastritis Strains. Infection and Immunity 2021; 89(6) doi: 10.1128/IAI.00053-21
|
| 55 |
Kazumi Inokuchi, Hideki Mori, Juntaro Matsuzaki, Kenro Hirata, Yosuke Harada, Yoshimasa Saito, Hidekazu Suzuki, Takanori Kanai, Tatsuhiro Masaoka. Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐lineHelicobacter pylorieradication regimen. Helicobacter 2022; 27(4) doi: 10.1111/hel.12900
|
| 56 |
Jing Yu, Yiming Lv, Peng Yang, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang. Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populations. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03002-z
|
| 57 |
Hiroyuki Eto, Sho Suzuki, Chika Kusano, Hisatomo Ikehara, Ryoji Ichijima, Hirotaka Ito, Koichi Kawabe, Masashi Kawamura, Yoshioki Yoda, Moriyasu Nakahara, Takuji Gotoda. Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy. Helicobacter 2021; 26(2) doi: 10.1111/hel.12788
|
| 58 |
Aya Elsayed Maghrabia, Hend Ali Elshebrawy, Mahmoud Ahmed Mahros, Mohammed Mohammed Elgazzar, Khalid Ibrahim Sallam. Clarithromycin-, and metronidazole-resistant Helicobacter pylori isolated from raw and ready-to-eat meat in Mansoura, Egypt. International Journal of Food Microbiology 2023; 387: 110052 doi: 10.1016/j.ijfoodmicro.2022.110052
|
| 59 |
Gianluca Z ROVARIS, João V BACK, Maria Paula RONCHI-COLOMBO, Vitória S ROSA, Manoel C B CARDOSO, Emilio C BERGER. ASSESSMENT OF THE ACCURACY OF THE RAPID TEST FOR THE DIAGNOSIS OF HELICOBACTER PYLORI IN PATIENTS THAT DIDN’T UNDERGO PREVIOUS ERADICATION THERAPY AND WHO WENT THROUGH ENDOSCOPY. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-136
|
| 60 |
Prabhav Kashyap Godavarthy, Chandra Puli. From Antibiotic Resistance to Antibiotic Renaissance: A New Era in Helicobacter pylori Treatment. Cureus 2023; doi: 10.7759/cureus.36041
|
| 61 |
Taslima Zaman, Ahsanul Haq, Rahnuma Ahmad, Susmita Sinha, Kona Chowdhury, Sultana Parvin, Mostofa Imran, Zaman U Humayra, Santosh Kumar, Mainul Haque. The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh. Cureus 2024; doi: 10.7759/cureus.56283
|
| 62 |
Jessyca Aparecida Paes Dutra, Suzana Gonçalves Carvalho, Aline Soares de Oliveira, Jéssica Raquel Borges Monteiro, Jéssica Rodrigues Pereira de Oliveira Borlot, Marcela Tavares Luiz, Tais Maria Bauab, Rodrigo Rezende Kitagawa, Marlus Chorilli.
Microparticles and nanoparticles-based approaches to improve oral treatment of
Helicobacter pylori
infection
. Critical Reviews in Microbiology 2023; : 1 doi: 10.1080/1040841X.2023.2274835
|
| 63 |
Glauber Rocha Lima Araújo, Hanna Santos Marques, Maria Luísa Cordeiro Santos, Filipe Antônio França da Silva, Breno Bittencourt da Brito, Gabriel Lima Correa Santos, Fabrício Freire de Melo. <i>Helicobacter pylori</i> infection: How does age influence the inflammatory pattern?. World Journal of Gastroenterology 2022; 28(4): 402-411 doi: 10.3748/wjg.v28.i4.402
|
| 64 |
Heena Tabassum, Iffat Zareen Ahmad. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from Nigella sativa L. that Inhibit Cag A and Vac A Oncoprotein of Helicobacter pylori: Probable Treatment of H. pylori Infections. Medicinal Chemistry 2020; 17(2): 146 doi: 10.2174/1573406416666200302113729
|
| 65 |
Junfei Ma, Jingxuan Qiu, Shuying Wang, Qianyu Ji, Dongpo Xu, Haiwang Wang, Zhiguang Wu, Qing Liu. A Novel Design of Multi-epitope Vaccine Against Helicobacter pylori by Immunoinformatics Approach. International Journal of Peptide Research and Therapeutics 2021; 27(2): 1027 doi: 10.1007/s10989-020-10148-x
|
| 66 |
Paulina Ortiz-Ramírez, Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Víctor Martínez-Rosas, Laura Morales-Luna, Roberto Arreguin-Espinosa, Rosa Angélica Castillo-Rodríguez, Luis Miguel Canseco-Ávila, Noemi Cárdenas-Rodríguez, Verónica Pérez de la Cruz, Alba Mónica Montiel-González, Fernando Gómez-Chávez, Saúl Gómez-Manzo. Biochemical and Kinetic Characterization of the Glucose-6-Phosphate Dehydrogenase from Helicobacter pylori Strain 29CaP. Microorganisms 2022; 10(7): 1359 doi: 10.3390/microorganisms10071359
|